A detailed history of Missouri Trust & Investment CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Missouri Trust & Investment CO holds 800 shares of NVO stock, worth $84,048. This represents 0.03% of its overall portfolio holdings.

Number of Shares
800
Previous 800 -0.0%
Holding current value
$84,048
Previous $114,000 16.67%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $36,376 - $79,816
400 Added 100.0%
800 $72,000
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $38,352 - $46,832
400 New
400 $45,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.